Aminopiperidine indazoles as orally efficacious melanin concentrating hormone receptor-1 antagonists.

The synthesis and biological evaluation of novel 3-amino indazole melanin concentrating hormone receptor-1 antagonists are reported, several of which demonstrated functional activity of less than 100nM. Compounds 19 and 28, two of the more potent compounds identified in this study, were characterized by high exposure in the brain and demonstrated robust efficacy when dosed in diet-induced obese mice.

[1]  Anil Vasudevan,et al.  Identification of aminopiperidine benzamides as MCHr1 antagonists. , 2005, Bioorganic & medicinal chemistry letters.

[2]  B. Lowell,et al.  Mice lacking melanin-concentrating hormone are hypophagic and lean , 1998, Nature.

[3]  S. Gammeltoft,et al.  A role for melanin-concentrating hormone in the central regulation of feeding behaviour , 1996, Nature.

[4]  S. Buchwald,et al.  Pd-catalyzed intermolecular amidation of aryl halides: the discovery that xantphos can be trans-chelating in a palladium complex. , 2002, Journal of the American Chemical Society.

[5]  Robin Shapiro,et al.  Identification of 2-(4-benzyloxyphenyl)-N- [1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-yl]acetamide, an orally efficacious melanin-concentrating hormone receptor 1 antagonist for the treatment of obesity. , 2005, Journal of medicinal chemistry.

[6]  J. Vaughan,et al.  The melanin‐concentrating hormone system of the rat brain: An immuno‐ and hybridization histochemical characterization , 1992, The Journal of comparative neurology.

[7]  Anil Vasudevan,et al.  Identification of ortho-amino benzamides and nicotinamides as MCHr1 antagonists. , 2005, Bioorganic & medicinal chemistry letters.

[8]  B. Lowell,et al.  Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. , 2001, The Journal of clinical investigation.

[9]  Andrew Browning,et al.  Recent developments in the discovery of melanin-concentrating hormone antagonists: novel antiobesity agents , 2004 .